Sfrp2-flox Mouse
Common Name
Sfrp2-flox
제품 ID
S-CKO-04972
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-20319-Sfrp2-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Sfrp2-flox Mouse (카탈로그 번호 S-CKO-04972)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Sfrp2-flox
품종 계통계통 ID
CKOCMP-20319-Sfrp2-B6J-VA
유전자명
제품 ID
S-CKO-04972
유전자 별칭
Sdf5
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 3
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000029625
NCBI 전사체 ID
NM_009144
타겟 영역
Exon 1
유효 영역 크기
~3.4 kb
유전자 연구 개요
Sfrp2, or Secreted frizzled-related protein 2, is a vital molecule in the Wnt signaling pathway. It can act as an antagonist of the canonical Wnt signaling pathway and is involved in regulating multiple biological processes such as organ development and disease processes [7].
In skin, Sfrp2 defines a major fibroblast population with distinct morphology and function compared to other fibroblast populations defined by genes like FMO1. Sfrp2+ fibroblasts are small, elongated, and distributed between collagen bundles, and differential gene expression suggests their role in matrix deposition [1].
In diabetic cardiomyopathy, Sfrp2 is downregulated, and its overexpression can reverse apoptosis and promote mitochondrial function in an AMPK-PGC1-α-dependent manner, while silencing endogenous Sfrp2 promotes glucolipotoxicity-induced mitochondrial dysfunction and apoptosis [2].
In radioimmunotherapy, conditional Sfrp2 knockout in cancer-associated fibroblasts (CAFs) boosts the abscopal effect by rewiring the vascular-immune microenvironment to promote CD8+ T cell recruitment to unirradiated tumors [3].
In aged-related melanoma, aged fibroblasts secrete sFRP2, which drives melanoma metastasis and therapy resistance through a multi-step signaling cascade [4].
In systemic sclerosis skin, SSc dermal myofibroblasts arise from an SFRP2hi/DPP4-expressing progenitor fibroblast population [5].
In idiopathic pulmonary fibrosis, a fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia [6].
In cardiomyogenesis, Sfrp2 promotes the differentiation of multipotent cKit(+) cells into cardiomyocytes in vivo, improving cardiac function in an injury model [8].
In preeclampsia, SFRP2 overexpression in JEG-3 cells reduces cell viability, proliferation, and migration, and increases apoptosis by inhibiting the Wnt/β-catenin pathway [9].
In diabetic wound healing, suppression of SFRP2 delays the wound healing process in diabetic mice, affects macrophage infiltration and functional phenotype transition, and energy metabolism [10].
In conclusion, Sfrp2 plays diverse and crucial roles in various biological processes and disease conditions. Studies using gene knockout or conditional knockout models in mice have revealed its significance in areas such as skin fibroblast function, diabetic cardiomyopathy, cancer therapy response, melanoma metastasis, fibrosis development, cardiomyogenesis, preeclampsia, and diabetic wound healing. These findings enhance our understanding of Sfrp2's biological functions and provide potential therapeutic targets for related diseases.
References:
1. Tabib, Tracy, Morse, Christina, Wang, Ting, Chen, Wei, Lafyatis, Robert. 2017. SFRP2/DPP4 and FMO1/LSP1 Define Major Fibroblast Populations in Human Skin. In The Journal of investigative dermatology, 138, 802-810. doi:10.1016/j.jid.2017.09.045. https://pubmed.ncbi.nlm.nih.gov/29080679/
2. Ma, Tianyi, Huang, Xiaohui, Zheng, Haoxiao, Hu, Yunzhao, Huang, Yuli. 2021. SFRP2 Improves Mitochondrial Dynamics and Mitochondrial Biogenesis, Oxidative Stress, and Apoptosis in Diabetic Cardiomyopathy. In Oxidative medicine and cellular longevity, 2021, 9265016. doi:10.1155/2021/9265016. https://pubmed.ncbi.nlm.nih.gov/34790288/
3. Zhang, Yan-Pei, Guo, Ze-Qin, Cai, Xiao-Ting, Wu, De-Hua, Dong, Zhong-Yi. 2025. PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy. In Cancer cell, 43, 856-874.e9. doi:10.1016/j.ccell.2025.02.024. https://pubmed.ncbi.nlm.nih.gov/40086438/
4. Kaur, Amanpreet, Webster, Marie R, Marchbank, Katie, Ribas, Antoni, Weeraratna, Ashani T. 2016. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. In Nature, 532, 250-4. doi:10.1038/nature17392. https://pubmed.ncbi.nlm.nih.gov/27042933/
5. Tabib, Tracy, Huang, Mengqi, Morse, Nina, Domsic, Robyn, Lafyatis, Robert. 2021. Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin. In Nature communications, 12, 4384. doi:10.1038/s41467-021-24607-6. https://pubmed.ncbi.nlm.nih.gov/34282151/
6. Cohen, Max L, Brumwell, Alexis N, Ho, Tsung Che, Chapman, Harold A, Le Saux, Claude Jourdan. 2024. A fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis. In The Journal of clinical investigation, 134, . doi:10.1172/JCI174598. https://pubmed.ncbi.nlm.nih.gov/38980870/
7. Wu, Yu, Liu, Xinyue, Zheng, Haoxiao, Huang, Xiaohui, Huang, Yuli. 2020. Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease. In International journal of biological sciences, 16, 730-738. doi:10.7150/ijbs.40923. https://pubmed.ncbi.nlm.nih.gov/32071544/
8. Gomez, José A, Payne, Alan, Pratt, Richard E, Hodgkinson, Conrad P, Dzau, Victor J. . A role for Sfrp2 in cardiomyogenesis in vivo. In Proceedings of the National Academy of Sciences of the United States of America, 118, . doi:10.1073/pnas.2103676118. https://pubmed.ncbi.nlm.nih.gov/34380738/
9. Lan, Ruihong, Yu, Yihong, Song, Jie, Xue, Mengdi, Gong, Humin. 2024. SFRP2 suppresses trophoblast cell migration by inhibiting the Wnt/β‑catenin pathway. In Molecular medicine reports, 29, . doi:10.3892/mmr.2024.13190. https://pubmed.ncbi.nlm.nih.gov/38426532/
10. Yang, Jiaqi, Xiong, Guorui, He, Huijuan, Huang, Haili. 2024. SFRP2 modulates functional phenotype transition and energy metabolism of macrophages during diabetic wound healing. In Frontiers in immunology, 15, 1432402. doi:10.3389/fimmu.2024.1432402. https://pubmed.ncbi.nlm.nih.gov/39464880/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
